导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.95% | 746/1050 |
| 近一周 | -1.37% | 537/1104 |
| 近一月 | -6.97% | 946/1103 |
| 近一季 | -14.34% | 846/1092 |
| 近半年 | -4.59% | 604/1070 |
| 近一年 | -1.93% | 623/1018 |
| 近两年 | 39.32% | 598/926 |
| 近三年 | -0.34% | 684/834 |
| 成立以来 | 104.96% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.72% 968/1070 |
30.13% 314/1101 |
- - |
- - |
| 2025 | 34.76% 404/1065 |
0.78% 736/1014 |
-3.61% 915/1038 |
41.15% 174/1050 |
-1.72% 543/1065 |
| 2024 | -15.46% 868/1011 |
-7.38% 668/960 |
-5.93% 686/983 |
10.24% 605/991 |
-11.98% 956/1011 |
| 2023 | -21.55% 702/952 |
1.22% 559/880 |
-3.20% 393/895 |
-13.68% 743/915 |
-7.24% 701/952 |
| 2022 | -32.37% 669/867 |
-17.90% 421/773 |
8.53% 326/806 |
-18.72% 731/845 |
-6.62% 689/867 |
| 2021 | 22.93% 134/740 |
0.08% 148/580 |
25.12% 89/659 |
-0.37% 220/704 |
-1.46% 492/740 |
| 2020 | 130.56% 4/554 |
-4.45% 271/419 |
32.16% 97/466 |
33.76% 3/517 |
36.49% 17/554 |
| 2019 | 54.74% 115/410 |
28.60% 450/1146 |
-6.28% 793/1228 |
4.13% 220/390 |
23.30% 7/410 |
| 2018 | - - |
- - |
- - |
-3.95% 413/1000 |
-10.66% 349/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 创金合信工业周期股票C VS. 东吴新产业精选股票A(580008) |